New cancer clinical trial: Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)

Published on: December 03, 2018 at 12:00PM
Condition:   Squamous-cell Non-small Cell Lung Cancer
Intervention:   Drug: Rogaratinib
Sponsor:   Swiss Group for Clinical Cancer Research
Not yet recruiting
https://ift.tt/2E1Sa4O